Citigroup Cuts Baxter International (NYSE:BAX) Price Target to $35.00
Baxter International (NYSE:BAX – Free Report) had its price objective cut by Citigroup from $37.00 to $35.00 in a report issued on Wednesday,Benzinga reports. They currently have a neutral rating on ...
American Association of Individual Investors1 天
Which Is a Better Investment, Baxter International Inc. or Boston Scientific Corporation Stock?
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The ...
Town Square Delaware1 天
Nationwide IV fluid shortage did not impact Delaware hospitals
“Nemours Children’s Health uses Baxter to supply intravenous fluids, but we have also worked with other manufacturers ... I ...
indepthnh1 天
As Hospitals Cancel Surgeries, Sununu Seeks Action From Biden Administration on IV Shortage
He said one of the state’s greatest concerns is there is no line of sight about national supplies of the various IV fluid ...
Plastics News4 天
Kickstart: GLP-1 growth drives medical expansions
The consumer demand for injectable medications to control diabetes and aid weight loss isn't slowing down. And that's going ...
moneycontrol.com4 小时
Baxter International
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
Yahoo Finance5 天
Baxter International Inc. (BAX)
After hours: 7:56:23 p.m. EST ...
Yahoo Finance4 天
Baxter International Inc. (BAX)
After hours: 7:35:10 pm GMT-5 ...